Objective Since the last epidemiologic review of neuromyelitis optica/neuromyelitis optica
spectrum disorder (NMO/NMOSD), 22 additional studies have been conducted. We …

Background During the last two decades, neuromyelitis optica spectrum disorder (NMOSD)
has undergone important changes, with new diagnostic markers and criteria, better …

Objective Compared to older Caucasians, older African Americans have higher risks of
developing Alzheimer disease (AD) and lower cerebrospinal fluid (CSF) tau biomarker …

Background Neuromyelitis optica spectrum disorders (NMOSD) is an increasing diagnostic
and therapeutic challenge in Latin America (LATAM). Despite the heterogeneity of this …

A major development over the past two decades was the recognition of recurrent
neuromyelitis optica (NMO) as a particular central nervous system disorder different from …

Background Literature regarding MS epidemiology and phenotype is scarce but has
increased markedly over the past years. The objective of the present work is to assess the …

Multiple sclerosis (MS) is a chronic, degenerative autoimmune inflammatory disease of the
central nervous system. The prevalence is different in every continent, changing according …

Background Neuromyelitis optica spectrum disorders (NMOSD), is a rare autoimmune
inflammatory disease of the central nervous system. Since the countries of Latin America …

Neuromyelitis optica spectrum disorder (NMOSD) is a rare and disabling neurological
disorder, marked by recurrent attacks of the central nervous system. NMO has a high female …

Background and Objectives Preventing relapses in neuromyelitis Optica spectrum disorder
(NMOSD) is a primary goal. New effective molecules are often expensive and not readily …